Beneficial islet inflammation in health depends on pericytic TLR/MyD88 signaling
Journal of Clinical Investigation · 2024
DOI: 10.1172/jci179335 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2024. Verfasst von Anat Schonblum und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell and Development Biology, Faculty of Medical and Health Sciences and. Hauptthemen laut MEDLINE: Myeloid Differentiation Factor 88, Pericytes, Signal Transduction, Inflammation. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union, Israel Science Foundation.
Abstract (Originalsprache)
While inflammation is beneficial for insulin secretion during homeostasis, its transformation adversely affects β cells and contributes to diabetes. However, the regulation of islet inflammation for maintaining glucose homeostasis remains largely unknown. Here, we identified pericytes as pivotal regulators of islet immune and β cell function in health. Islets and pancreatic pericytes express various cytokines in healthy humans and mice. To interfere with the pericytic inflammatory response, we selectively inhibited the TLR/MyD88 pathway in these cells in transgenic mice. The loss of MyD88 impaired pericytic cytokine production. Furthermore, MyD88-deficient mice exhibited skewed islet inflammation with fewer cells, an impaired macrophage phenotype, and reduced IL-1β production. This aberrant pericyte-orchestrated islet inflammation was associated with β cell dedifferentiation and impaired glucose response. Additionally, we found that Cxcl1, a pericytic MyD88-dependent cytokine, promoted immune IL-1β production. Treatment with either Cxcl1 or IL-1β restored the mature β cell phenotype and glucose response in transgenic mice, suggesting a potential mechanism through which pericytes and immune cells regulate glucose homeostasis. Our study revealed pericyte-orchestrated islet inflammation as a crucial element in glucose regulation, implicating this process as a potential therapeutic target for diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cell and Development Biology, Faculty of Medical and Health Sciences and.
- Department of Human Molecular Genetics and Biochemistry, Faculty of Medical and Health Sciences and Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.
Förderung
- European Union
- Israel Science Foundation
Zitieren
APA
Schonblum, A., Ali Naser, D., Ovadia, S., Egbaria, M., Puyesky, S., Epshtein, A., Wald, T., Mercado-Medrez, S., Ashery-Padan, R., & Landsman, L. (2024). Beneficial islet inflammation in health depends on pericytic TLR/MyD88 signaling. Journal of Clinical Investigation. https://doi.org/10.1172/jci179335
Vancouver
Schonblum A, Ali Naser D, Ovadia S, Egbaria M, Puyesky S, Epshtein A, et al. Beneficial islet inflammation in health depends on pericytic TLR/MyD88 signaling. Journal of Clinical Investigation. 2024. doi:10.1172/jci179335
BibTeX
@article{Schonblum2024,
author = {Schonblum, Anat and Ali Naser, Dunia and Ovadia, Shai and Egbaria, Mohammed and Puyesky, Shani and Epshtein, Alona and Wald, Tomer and Mercado-Medrez, Sophia and Ashery-Padan, Ruth and Landsman, Limor},
title = {Beneficial islet inflammation in health depends on pericytic TLR/MyD88 signaling},
journal = {Journal of Clinical Investigation},
year = {2024},
doi = {10.1172/jci179335}
}
EUVIMED